Emeritus Corp (ESC) 29.90 $ESC
Faruqi & Faruqi, LLP Investigates The Proposed Sale of Emeritus Corp. to Brookdale Senior Living Inc.
Business Wire - Thu Apr 17, 2:59PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, investigates a possible challenge of the Board of Directors of Emeritus Corp. ("Emeritus" or the "Company"
(NYSE:ESC) actions as they relate to their recommendation and agreement of the sale of the Company to Brookdale Senior Living Inc. ("Brookdale" for approximately $1.4 billion. The Company's stockholders are offered to receive 0.95 shares of Brookdale for each share of Emeritus common stock they own. A complaint has been filed against the Company.
Brookdale Senior Living and Emeritus Senior Living Announce Expiration of HSR Act Waiting Period
PR Newswire - Thu Apr 17, 8:00AM CDT
Brookdale Senior Living Inc. (NYSE: BKD) and Emeritus Corporation (NYSE: ESC) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with the previously announced proposed merger of Brookdale and Emeritus.
Shares of ESC Up 39.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 15, 4:48PM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 5 months, Emeritus has returned 39.64% as of today's recent price of $29.54.
Healthcare Companies Report Results, Patents, and Stock Movements - Analyst Notes on Puma Biotechnology, Alnylam, INSYS Therapeutics, Peregrine Pharmaceuticals, and VIVUS
PR Newswire - Thu Apr 10, 11:28AM CDT
Today, Analysts Review released its analysts' notes regarding Puma Biotechnology, Inc. (NYSE: PBYI), Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), INSYS Therapeutics, Inc. (NASDAQ: INSY), Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM), and VIVUS Inc (NYSE: ESC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
New Leadership Appointments, Stock Price Movements, Partnerships, and Philanthropic Initiatives - Analyst Notes on Brookdale, Kindred, Envision Healthcare, Select Medical, and Emeritus
PR Newswire - Thu Apr 10, 10:26AM CDT
Today, Analysts Review released its analysts' notes regarding Brookdale Senior Living Inc. (NYSE: BKD), Kindred Healthcare Inc. (NYSE: KND), Envision Healthcare Holdings, Inc. (NYSE: EVHC), Select Medical Holdings Corporation (NYSE: SEM), and Emeritus Corp. (NYSE: ESC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
45.5% Return Seen to Date on SmarTrend Emeritus Call (ESC)
Comtex SmarTrend(R) - Tue Apr 08, 11:00AM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 5 months, Emeritus has returned 45.50% as of today's recent price of $30.78.
Uptrend Call Working As Emeritus Stock Rises 50.2% (ESC)
Comtex SmarTrend(R) - Tue Apr 01, 9:39AM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 5 months, Emeritus has returned 50.18% as of today's recent price of $31.77.
Emeritus Continues Its Fight Against Poor Nutrition for Seniors
GlobeNewswire - Tue Apr 01, 7:00AM CDT
For the second year in row, Emeritus Senior Living (NYSE:ESC) is seeking to help combat senior malnutrition by delivering more than 10,000 meals to seniors across America in the next 60 days in honor of National Food Month in April.
Emeritus Up 47.0% Since SmarTrend Uptrend Call (ESC)
Comtex SmarTrend(R) - Tue Mar 25, 9:15AM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 5 months, Emeritus has returned 47.01% as of today's recent price of $31.10.
Shorts Are Piling Into These Stocks. Should You Be Worried?
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 24, 4:05PM CDT
The best thing about the stock market is that you can make money in either direction . Historically, stock indexes tend to trend upward over the long term. But when you look at individual stocks, you'll find plenty that lose money over the long...
INVESTOR ALERT: LEVI & KORSINSKY, LLP Notifies Investors of EMERITUS CORP. of Class Action Against Its Board of Directors In Connection With the Sale of the Company to Brookdale Senior Living Inc. -- ESC
GlobeNewswire - Tue Mar 18, 10:49AM CDT
Levi & Korsinsky notifies investors of Emeritus Corp. ("Emeritus" or "the Company" (NYSE:ESC) of claims of breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Brookdale Senior Living Inc. ("Brookdale" (NYSE:BKD). A complaint was filed in Washington state court.
Emeritus Has Returned 46.0% Since SmarTrend Recommendation (ESC)
Comtex SmarTrend(R) - Mon Mar 17, 5:16PM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 4 months, Emeritus has returned 45.97% as of today's recent price of $30.88.
Shares of ESC Up 46.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 10, 11:04AM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 4 months, Emeritus has returned 46.49% as of today's recent price of $30.99.
Earnings Look Back: Emeritus Is Up 46.7% Since Reporting Quarterly Results 2 Weeks Ago (ESC)
Comtex SmarTrend(R) - Mon Mar 10, 8:38AM CDT
Two weeks ago on February 20th, 2014 Emeritus (NYSE:ESC) reported earnings and analysts, on average, expected a loss of $0.31 on sales of $520.8 million. The company actually reported a loss of $0.91 per share on sales of $520.6 million, missing EPS estimates by $0.60 and matching revenue estimates. Shares of Emeritus have climbed from $21.46 to $31.49, representing a gain of 46.7% since the company reported earnings 18 days ago.
INVESTOR ALERT - EMERITUS CORP.: The Law Offices of Vincent Wong Investigate the Sale of EMERITUS CORP. to Brookdale Senior Living Inc.
Business Wire - Thu Mar 06, 3:10PM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Emeritus Corp. (NYSE:ESC) ("Emeritus" in connection with the sale of the Company to Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" .
Insider Trading Alert - WMT, GE And ESC Traded By Insiders
at The Street - Wed Mar 05, 12:15PM CST
Stocks with insider trader activity include WMT, GE and ESC
Faruqi & Faruqi, LLP Investigates The Proposed Sale of Emeritus Corp. to Brookdale Senior Living Inc.
Business Wire - Thu Apr 17, 2:59PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, investigates a possible challenge of the Board of Directors of Emeritus Corp. ("Emeritus" or the "Company"
(NYSE:ESC) actions as they relate to their recommendation and agreement of the sale of the Company to Brookdale Senior Living Inc. ("Brookdale" for approximately $1.4 billion. The Company's stockholders are offered to receive 0.95 shares of Brookdale for each share of Emeritus common stock they own. A complaint has been filed against the Company. Brookdale Senior Living and Emeritus Senior Living Announce Expiration of HSR Act Waiting Period
PR Newswire - Thu Apr 17, 8:00AM CDT
Brookdale Senior Living Inc. (NYSE: BKD) and Emeritus Corporation (NYSE: ESC) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with the previously announced proposed merger of Brookdale and Emeritus.
Shares of ESC Up 39.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 15, 4:48PM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 5 months, Emeritus has returned 39.64% as of today's recent price of $29.54.
Healthcare Companies Report Results, Patents, and Stock Movements - Analyst Notes on Puma Biotechnology, Alnylam, INSYS Therapeutics, Peregrine Pharmaceuticals, and VIVUS
PR Newswire - Thu Apr 10, 11:28AM CDT
Today, Analysts Review released its analysts' notes regarding Puma Biotechnology, Inc. (NYSE: PBYI), Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), INSYS Therapeutics, Inc. (NASDAQ: INSY), Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM), and VIVUS Inc (NYSE: ESC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
New Leadership Appointments, Stock Price Movements, Partnerships, and Philanthropic Initiatives - Analyst Notes on Brookdale, Kindred, Envision Healthcare, Select Medical, and Emeritus
PR Newswire - Thu Apr 10, 10:26AM CDT
Today, Analysts Review released its analysts' notes regarding Brookdale Senior Living Inc. (NYSE: BKD), Kindred Healthcare Inc. (NYSE: KND), Envision Healthcare Holdings, Inc. (NYSE: EVHC), Select Medical Holdings Corporation (NYSE: SEM), and Emeritus Corp. (NYSE: ESC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
45.5% Return Seen to Date on SmarTrend Emeritus Call (ESC)
Comtex SmarTrend(R) - Tue Apr 08, 11:00AM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 5 months, Emeritus has returned 45.50% as of today's recent price of $30.78.
Uptrend Call Working As Emeritus Stock Rises 50.2% (ESC)
Comtex SmarTrend(R) - Tue Apr 01, 9:39AM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 5 months, Emeritus has returned 50.18% as of today's recent price of $31.77.
Emeritus Continues Its Fight Against Poor Nutrition for Seniors
GlobeNewswire - Tue Apr 01, 7:00AM CDT
For the second year in row, Emeritus Senior Living (NYSE:ESC) is seeking to help combat senior malnutrition by delivering more than 10,000 meals to seniors across America in the next 60 days in honor of National Food Month in April.
Emeritus Up 47.0% Since SmarTrend Uptrend Call (ESC)
Comtex SmarTrend(R) - Tue Mar 25, 9:15AM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 5 months, Emeritus has returned 47.01% as of today's recent price of $31.10.
Shorts Are Piling Into These Stocks. Should You Be Worried?
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 24, 4:05PM CDT
The best thing about the stock market is that you can make money in either direction . Historically, stock indexes tend to trend upward over the long term. But when you look at individual stocks, you'll find plenty that lose money over the long...
INVESTOR ALERT: LEVI & KORSINSKY, LLP Notifies Investors of EMERITUS CORP. of Class Action Against Its Board of Directors In Connection With the Sale of the Company to Brookdale Senior Living Inc. -- ESC
GlobeNewswire - Tue Mar 18, 10:49AM CDT
Levi & Korsinsky notifies investors of Emeritus Corp. ("Emeritus" or "the Company"
(NYSE:ESC) of claims of breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Brookdale Senior Living Inc. ("Brookdale" (NYSE:BKD). A complaint was filed in Washington state court. Emeritus Has Returned 46.0% Since SmarTrend Recommendation (ESC)
Comtex SmarTrend(R) - Mon Mar 17, 5:16PM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 4 months, Emeritus has returned 45.97% as of today's recent price of $30.88.
Shares of ESC Up 46.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 10, 11:04AM CDT
SmarTrend identified an Uptrend for Emeritus (NYSE:ESC) on November 7th, 2013 at $21.16. In approximately 4 months, Emeritus has returned 46.49% as of today's recent price of $30.99.
Earnings Look Back: Emeritus Is Up 46.7% Since Reporting Quarterly Results 2 Weeks Ago (ESC)
Comtex SmarTrend(R) - Mon Mar 10, 8:38AM CDT
Two weeks ago on February 20th, 2014 Emeritus (NYSE:ESC) reported earnings and analysts, on average, expected a loss of $0.31 on sales of $520.8 million. The company actually reported a loss of $0.91 per share on sales of $520.6 million, missing EPS estimates by $0.60 and matching revenue estimates. Shares of Emeritus have climbed from $21.46 to $31.49, representing a gain of 46.7% since the company reported earnings 18 days ago.
INVESTOR ALERT - EMERITUS CORP.: The Law Offices of Vincent Wong Investigate the Sale of EMERITUS CORP. to Brookdale Senior Living Inc.
Business Wire - Thu Mar 06, 3:10PM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Emeritus Corp. (NYSE:ESC) ("Emeritus"
in connection with the sale of the Company to Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" . Insider Trading Alert - WMT, GE And ESC Traded By Insiders
at The Street - Wed Mar 05, 12:15PM CST
Stocks with insider trader activity include WMT, GE and ESC
